SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: NNLX - NanoLogix, Incorporated

07 Feb 2017 11:41 AM
05 Feb 2013 02:32 PM
05 Feb 2013 12:19 PM
04 Feb 2013 10:28 PM
15 Mar 2006 02:45 AM <--

Return to NNLX - NanoLogix, Incorporated
 
NanoLogix, Inc. (Pink NNLX): is a biotechnology / genomics company owning 31 issued patents with applications in nanotechnology, hydrogen gas production, medical drugs/devices, bio-defense sensors and bioremediation. Nanotechnology applications include Biochips embedded in small transportable devices for rapid bacteria identification of disease causing pathogens, and Bio Micro Electro Mechanical Systems (“BioMEMS”) for rapid environmental microbial monitoring with bio-defense implications. Its hydrogen bioreactor research is designed to assist in worldwide energy independence and reduce pollution using renewable, environmentally-friendly energy sources.
Website: nanologix.net